UPDATE : Tuesday, October 15, 2019
Will Tagrisso study results affect use of EGFR TKIs in lung cancer?
AstraZeneca’s imminent announcement of overall survival (OS) data of Tagris...
by Kim Yun-mi  |  2019-09-18 11:36
Hanmi spurs new immunotherapy development through open innovation
Hanmi Pharmaceutical said it is launching new development projects in the f...
by Lee Han-soo  |  2019-09-17 18:14
‘Lundbeck to work with parliament to prevent suicide in Korea’
Lundbeck, which sells anti-depressants Lexapro and Brintellix, dementia tre...
by Kim Yun-mi  |  2019-09-17 15:19
Shinpoong's malaria treatment expands global presence
Shinpoong Pharmaceutical said that Pyramax, its malaria treatment, is quick...
by Lee Han-soo  |  2019-09-17 15:13
SK Bioscience to export influenza vaccine to Asian countries
SK Bioscience will export 250,000 doses of Skycellflu, the first cell-cultu...
by Lee Han-soo  |  2019-09-17 11:27
Lenvima to get benefit as 1st-line treatment of hepatocellular carcinoma
Lenvima (ingredient: lenvatinib), a new liver cancer drug that arrived in a...
by Kim Yun-mi  |  2019-09-16 16:20
'Roche Korea to put patient accessibility first'
Roche Korea, the number one company in the domestic anticancer market, is l...
by Lee Han-soo  |  2019-09-16 15:41
GC’s Hunter syndrome drug to get priority screening in China
GC said that China’s National Medical Products Administration (NMPA) has de...
by Lee Han-soo  |  2019-09-16 13:56
GSK’s chronic hand eczema treatment faces local competition
GSK Korea is facing competition from DongKoo Bio&Pharma for its exclusive c...
by Lee Han-soo  |  2019-09-12 07:22
Chong Kun Dang wins patent suit against Novartis over immunosuppressant
Chong Kun Dang said it has won the lawsuit against Novartis over the patent...
by Jeong Sae-im  |  2019-09-11 15:16
AstraZeneca to challenge Roche in small-cell lung cancer treatment market
AstraZeneca’s Imfinzi (ingredient: durvalumab) has sharpened up its weapon ...
by Kim Yun-mi  |  2019-09-11 14:18
Amgen fetes 1st anniversary of getting expanded indication for Repatha
Amgen Korea said that its cardio-vascular disease business unit has held an...
by Lee Han-soo  |  2019-09-11 13:56
Hanmi to launch 3-substance combination in Latin America
Hanmi Pharmaceutical said that it has become the first local corporation to...
by Lee Han-soo  |  2019-09-11 13:56
Daewoong to test botulinum toxin Nabota for hair loss
Daewoong Pharmaceutical said it would conduct a clinical trial on botulinum...
by Jeong Sae-im  |  2019-09-11 13:56
Novartis withdraws suit against Ahngook’s generic drug
Novartis canceled its lawsuit against Ahngook Pharmaceutical’s anti-diabeti...
by Jeong Sae-im  |  2019-09-10 15:38
Immunotherapies Opdivo, Keytruda score high in real setting
Immunotherapies Opdivo Inj. and Keytruda Inj. showed excellent efficacy and...
by Kim Eun-young  |  2019-09-10 12:49
'Xarelto has superior renal preservation benefits in atrial fibrillation patients’
Bayer said that it has presented two real-world research results that have ...
by Lee Han-soo  |  2019-09-09 16:54
Hanmi to unveil investigator-led P2 progress for cancer treatment
Hanmi said that MD Anderson Cancer Center has presented the development of ...
by Lee Han-soo  |  2019-09-09 15:47
Novo Nordisk's Ryzodeg leads Korean mixed insulin market
Novo Nordisk Korea said Monday that Ryzodeg, the company's soluble insu...
by Lee Han-soo  |  2019-09-09 14:18
PARP inhibitors to show intense rivalry at ESMO 2019
The highlight of the upcoming ESMO 2019, a cancer meeting in Europe, will b...
by Kim Yun-mi  |  2019-09-09 11:56
Back to Top